Vapotherm, Inc. is the inventor of high flow nasal cannula, and its advanced form: Vapotherm high velocity therapy. Delivering high velocity therapy, the Precision Flow® system offers clinicians a reliable tool for multiple patient populations. For respiratory distress patients presenting in the ED and ICU, high velocity therapy can provide not just oxygenation, but also Mask-Free NIV®—ventilatory support with the comfort of heated humidified high flow.
Location: United States, New Hampshire, Exeter
Employees: 11-50
Phone: +1 844-381-8276
Total raised: $266M
Investors 2
| Date | Name | Website |
| - | Gilde Heal... | gildehealt... |
| - | Perceptive... | perceptive... |
Funding Rounds 7
| Date | Series | Amount | Investors |
| 11.05.2020 | - | $87M | - |
| 14.11.2018 | IPO | $56M | - |
| 15.01.2016 | - | $30M | - |
| 15.07.2015 | - | $20M | - |
| 13.03.2015 | Series C | $20M | - |
| 04.04.2014 | - | $24M | Gilde Heal... |
| 24.04.2013 | - | $29M | - |
Mentions in press and media 13
| Date | Title | Description |
| 17.06.2024 | Vapotherm Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going Private | EXETER, N.H., June 17, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has signed a definitive merger agreement with a newly-formed entity organized and funded ... |
| 11.05.2020 | Vapotherm raises $87 million via public offering | Utrecht (the Netherlands), Cambridge, Massachusetts (USA) – Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of... |
| 14.11.2018 | Vapotherm raises $56M via an IPO at NYSE | Utrecht (The Netherlands), Cambridge (United States) – Respiratory device producer Vapotherm, Inc. announced its Initial Public Offering and listing on the NYSE exchange. Shares in the IPO are issued to institutional investors in the US and... |
| 24.11.2015 | Vapotherm Inc. Announces $30 Million Financing Round | EXETER, NH,– Vapotherm, Inc., announced today it closed a $30 million equity financing last month. The first tranche of $15 million closed on October 30, 2015, and the second tranche is scheduled to close in September 2016. Arnerich Massena... |
| 15.07.2015 | Breathing tube maker Vapotherm raises $20M | Calls to Vapotherm about this new funding round have yet to be returned. Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis has undermined the economy and made people with chronic conditions m... |
| 13.03.2015 | Vapotherm Inc Closes $20 Million Series C Financing Round | EXETER, NH – Vapotherm, Inc., a developer and manufacturer of advanced respiratory care technology, today announced the closing of a $20MM equity financing. 3x5 Specialty Opportunity Fund led the financing round, which also included current... |
| 07.04.2014 | Gilde Healthcare leads $24 million financing round of respiratory care provider Vapotherm | EXETER, New Hampshire - Vapotherm, Inc. announced a $24MM financing round led by Gilde Healthcare. Adage Capital Management joined as new co-investor. The round was completed by existing investors Morgenthaler Ventures, Kaiser Permanente, 3... |
| 04.04.2014 | Vapotherm Closes $24M Financing | Vapotherm, an Exeter, New Hampshire-based manufacturer of advanced respiratory care devices, closed a $24m financing round. The round was led by Gilde Healthcare Partners, L.P., with participation new investor Adage Capital Management, L.P.... |
| 25.04.2013 | Vapotherm Closes $29M Financing | EXETER, NH, Vapotherm closed a $29M financing round which was led by the 3x5 Special Opportunity Fund. >> Click here for more funding data on Vapotherm >> To export Vapotherm funding data to PDF and Excel, click here Vapo... |
| 24.04.2013 | Vapotherm Closes $29M Financing | Vapotherm, an Exeter, New Hampshire-based manufacturer of advanced respiratory care devices, closed a $29m financing round. The round was led by the 3×5 Special Opportunity Fund L.P., with participation from new investor Morgenthaler Ventur... |
Show more